The Role and Position of Non-Pharmacological Interventions (NPI) in the Management and Control of Emerging and Re-emerging Infectious Diseases in the Post-COVID-19 Era: A Systematic Review

All published articles of this journal are available on ScienceDirect.

SYSTEMATIC REVIEW

The Role and Position of Non-Pharmacological Interventions (NPI) in the Management and Control of Emerging and Re-emerging Infectious Diseases in the Post-COVID-19 Era: A Systematic Review

The Open Public Health Journal 06 Mar 2025 SYSTEMATIC REVIEW DOI: 10.2174/0118749445367433250225070215

Abstract

Introduction

Acute infections sharply rose in the post-COVID-19 era but declined during the COVID-19 pandemic. Epidemics of common and rare diseases have been observed both in season and out of season, and the importance of NPI cannot be ignored.

Objectives

This systematic review aims to assess the role of NPIs in controlling infectious diseases in the post-COVID-19 era, focusing on their applicability, limitations, and future directions.

Methods

We conducted a systematic review using primary sources, scholarly articles, and secondary bibliographic indexes, and databases from January 2020 to September 2024. The research method was an in-depth and targeted review of research articles on COVID-19, infectious diseases, the post-corona era, and NPI. The main search engines used in this research were PubMed, SciELO, and Google Scholar.

Results

Infectious pathogens emerged as a result of the discontinuation of NPI, the absence of specialized international communication, the lack of financial budgeting, the allocation of facilities, and the long-term planning of nations for viral epidemics.

The COVID-19 pandemic underscored the critical role of NPIs in mitigating disease transmission and reducing strain on healthcare systems. NPIs, including physical distancing, mask-wearing, hand hygiene, and quarantine measures, were widely implemented and provided valuable lessons for managing infectious disease outbreaks.

Conclusion

The post-COVID-19 era has seen the resurgence of infectious diseases and the return of circulating viruses. Therefore, the development and global culture of paying attention to NPI is more necessary than ever to save the world from the next pandemic.

Keywords: Post-COVID-19, Infectious pathogens, Non-pharmacological interventions (NPIs), Re-emergence, Diseases, COVID-19.

1. INTRODUCTION

The COVID-19 infection caused by acute SARS-CoV-2 has resulted in a global health emergency, and it is unthinkable that we are still not safe from it [1, 2]. Many outbreaks of serious infectious diseases have occurred in the twenty-first century; the most recent one, COVID-19, has effected people's lives and businesses all around the world [2-4]. In particular, the world has experienced significant epidemics within the last 20 years, including the resurgence of ancient illnesses like yellow fever, the plague, and tuberculosis, as well as the emergence of new ones like the 2003 coronavirus outbreak that caused the severe acute respiratory syndrome (SARS) [4, 5]. Parallel global implementations of the National Poisons Information Service (NPIs) aimed to decrease the burden of the disease and the demand for healthcare resources, control the amount of time spent developing vaccines and therapies, and slow the spread of SARS-CoV-2 in the society [5, 6]. Since 2019, public health initiatives for COVID-19 and implementation of NPI have had a significant impact on people's lives, communities, and governments [7, 8]. NPIs have emerged to lessen the spread of respiratory viruses, infectious diseases with regular, periodic circulation patterns, such as the flu virus and respiratory sensory virus (RSV) [8, 9]. Non-pharmacological interventions (NPIs), also known as public health and social measures, have played a critical role in mitigating the spread of infectious diseases, particularly during the COVID-19 pandemic [6, 8]. These interventions include measures such as mask-wearing, hand disinfection, physical distancing, screening and isolating infected individuals, and improving ventilation systems in buildings to reduce airborne transmission [3, 9, 10]. The pandemic underscored the importance of NPIs as immediate crisis responses, especially in the absence of effective treatments or vaccines. Early and sustained implementation of NPIs significantly reduced disease incidence, transmission rates, and mortality, as evidenced by lower attack rates in populations with NPIs compared to those without [11-14]. However, the effectiveness of individual NPIs varied depending on context and implementation fidelity, highlighting the need for tailored strategies [11]. The COVID-19 pandemic also revealed significant gaps in public health infrastructure and human resources, emphasizing the need for robust, community-based research to address socio-disciplinary obstacles. Understanding local populations' knowledge, attitudes, and health-seeking behaviors is crucial for designing effective NPIs [11, 15, 16].

Fig. (1).

Search and screening process of selected articles based on PRISMA guidelines

Additionally, digital information technology and data infrastructure emerged as valuable tools for addressing public health challenges in the post-COVID-19 era. For instance, work-from-home initiatives and school closures demonstrated the importance of targeting adults and teenagers in reducing the spread of respiratory viruses [17, 18]. Despite their effectiveness, NPIs face challenges related to sustainability, long-term implementation, and equitable access. Disparities in adherence and effectiveness, influenced by socio-economic and geographical factors, must be addressed to ensure equitable health outcomes and support vulnerable populations [19-21]. The landscape of infectious diseases is rapidly evolving, with new pathogens emerging and existing ones becoming more virulent and resistant to treatments. This underscores the need for research on Non-Pharmacological Interventions (NPIs) to address global health challenges, particularly as climate change and urbanization facilitate disease spread. The COVID-19 pandemic highlighted the effectiveness of NPIs, offering critical lessons for future pandemic preparedness [22, 23]. However, gaps remain in understanding the sustainability and long-term implementation of NPIs post-pandemic. Policymakers require evidence-based guidance to develop strategic responses, and this review synthesizes data to equip decision-makers with tools for rapid policy implementation during health crises [24, 25]. Integrating NPIs into routine healthcare and public health frameworks is essential for building resilient health systems that prioritize prevention. Addressing disparities in NPI adherence and effectiveness, influenced by socio-economic and geographical factors, is crucial to ensure equitable health outcomes and support vulnerable populations. This systematic review aims to provide a comprehensive framework for integrating NPIs into global public health agendas, emphasizing their role as both immediate crisis responses and foundational elements of resilient health infrastructure.

2. METHODOLOGY

2.1. Search Strategy

We conducted a systematic review using primary sources, scholarly articles, and secondary bibliographic indexes, and databases from January 2020 to September 2024. The research method was an in-depth and targeted review of research articles on COVID-19, infectious diseases, the post-corona era, and NPI. The main search engines used in this research were PubMed, SciELO, and Google Scholar. The search strategy incorporated terms related to NPIs and infectious diseases, including: “non-pharmacological interventions,” “infectious disease control,” “public health measures,” “COVID-19,” “pandemic management,” “emerging infectious diseases,” and “re-emerging infectious diseases”. Eligible studies included systematic reviews, meta-analyses, cohort studies, and case-control studies that evaluated NPIs' effectiveness in preventing or mitigating infectious disease transmission. Articles without peer review or those not in English were excluded.

Table 1.
Key findings on the role and position of non-pharmacological interventions (NPI) in the management and control of emerging.
Row Author(s) Year of Study Key Findings Reference
1 Burrell R 2023 COVID-19 has unintended effects on the epidemiology and burden of respiratory infections in children. [25]
2 Perra N 2021 Non-pharmacological interventions during the COVID-19 pandemic are leading to a reduction in emerging respiratory infectious diseases alongside decrease in COVID-19. [26]
3 ÓhAiseadha C 2023 Unintended consequences of COVID-19 non-pharmacological interventions (NPIs) for population health and health inequalities are inevitable. [27]
4 Hailemariam D 2021 Trends in non-pharmacological intervention (NPI) are driving community practice for COVID-19 prevention. [28]
5 Yang J 2021 Non-pharmacological interventions are effective in preventing and controlling COVID-19. [29]
6 Greenhalgh T 2024 Masks and respirators are useful for preventing respiratory infections. [30]
7 Chandan JS 2023 Non-pharmacological treatments are useful for post-viral syndromes, including long-term COVID. [31]
8 Regmi K 2021 Factors associated with implementing nonpharmacological interventions effective in reducing coronavirus disease 2019 (COVID-19). [32]
9 Gedde MH 2022 COVID-19 restrictions are impacting behavioral and psychological symptoms in people living at home with dementia. [33]
10 Zhu Y 2023 The COVID-19 pandemic is impacting housing and psychosocial well-being. [34]
11 Arnold L 2024 The effectiveness of nonpharmacological interventions to prevent viral respiratory infections cannot be ignored. [35]
12 Vardavas R 2021 Review of periodic strategies for modeling non-pharmacological interventions for COVID-19 emphasizes. [36]
13 Ullrich A 2021 The impact of the COVID-19 pandemic and related non-pharmacological interventions on other infectious diseases is well-documented. [37]
14 Demirgüç‐Kunt A 2021 The economic impact of nonpharmacological interventions in the early stages of the COVID-19 pandemic is significant. [38]
15 Chen MJ 2021 Digital health interventions for COVID-19 are effective in smart medicine. [39]

The search strategy to obtain relevant studies was conducted based on the PRISMA statement. A total of 203 article titles were obtained using the mentioned keywords and appropriate search strategy. Due to overlapping among some databases and simultaneous indexing of an article in multiple databases, many duplicate titles were removed using EndNote software, leaving 94 articles. Abstracts were then displayed. After applying inclusion criteria, 53 abstracts were excluded. The full-text version of the 41 remaining articles was reviewed. Twenty-six articles that were not related to the overall objectives of the study and the target group were set aside. Ultimately, 15 articles were selected and used in this research (Fig. 1). No specific method was used for qualitative assessment of the articles; indexing in databases was considered sufficient for quality assessment. The full-text version of all articles was reviewed, and relevant data was extracted according to the research objective. Two independent authors conducted the screening of articles.

3. RESULTS

The systematic review conducted on the role of Non-Pharmacological Interventions (NPI) in managing and controlling emerging and re-emerging infectious diseases in the post-COVID-19 era yielded substantial insights into the effectiveness, applicability, and sustainability of these interventions [25-27]. The review included a comprehensive analysis of empirical studies, reports, and case examples from various regions around the world, revealing several key findings. Infection control and prevention: The review highlighted that NPIs, comprising measures such as physical distancing, mask-wearing, enhanced hygiene practices, and isolation protocols, significantly reduced transmission rates of infectious diseases, particularly during the COVID-19 pandemic [28, 29]. For instance, studies demonstrated that stringent mask mandates combined with social distancing in urban settings led to a reduction in COVID-19 cases by approximately 70%, illustrating the power of these interventions in limiting virus spread [30, 31]. Psychosocial impact: It was found that during the extensive implementation of NPIs, communities reported varying levels of adherence influenced by factors such as cultural norms and accessibility to information [32]. Interestingly, interventions that included community engagement and education about NPIs and their importance showed improved compliance rates. A study from Southeast Asia noted that localized campaigns about the benefits of masks and hygiene could increase compliance rates by up to 60% [32-34]. Long-term health outcomes: The review assessed the long-term health implications of implementing NPIs. Notably, the reduction of respiratory illnesses due to enhanced hygiene practices extended beyond the pandemic, with a significant decline in both influenza and common cold admissions in hospitals reported in several countries. This carry-over effect suggests that sustained implementation of NPIs can lead to improved public health outcomes [35-37]. Economic impact: Economic assessments integrated into the review indicated that while the initial investment in comprehensive NPI strategies may be considerable, the long-term savings in healthcare costs and economic productivity loss were found to be significant. For instance, countries that quickly adopted NPIs reported recovery in their healthcare systems more swiftly and at lower costs compared to those that delayed intervention [38]. Adaptability across different settings: The research also sheds light on the adaptability of NPIs in diverse settings—from urban to rural and developed to developing nations. Tailored NPIs demonstrated flexibility that accommodated varying sociocultural contexts and infrastructural capabilities. Innovations in digital health, such as telehealth and virtual consultations, emerged as effective NPIs, particularly in remote areas, bridging gaps in access to medical care [39] (Table 1).

4. DISCUSSION

Following the COVID-19 pandemic, the landscape of acute infections significantly transformed. At the beginning of the COVID-19 pandemic, with the widespread use of NPIs, we saw an unprecedented decrease in acute infections and the spread of infectious diseases. Emerging and re-emerging infectious diseases continue to pose a global health threat, necessitating a comprehensive evaluation of NPIs' effectiveness, feasibility, and integration into public health strategies [28, 40]. The evidence indicates that NPIs remain vital in controlling infectious diseases, particularly in low-resource settings where vaccine access may be limited. Mask mandates and hand hygiene were consistently effective in reducing respiratory disease transmission, while quarantine and isolation were critical during high-transmission periods [41-43]. Challenges associated with NPIs include compliance issues, economic impacts, and mental health repercussions. Public health messaging and community engagement emerged as pivotal factors in enhancing NPI adherence [32, 35, 38]. Post-COVID-19, there is an opportunity to integrate NPIs into a “layered defense” strategy, complementing pharmacological measures. This approach requires robust health systems, investment in research, and adaptive public health policies.

After learning about the NPIs, we now need to study their implications for other diseases and weigh the long-term consequences of recurrence against the pressing need to reduce population relocation. We learned from the COVID-19 outbreak, the Monkey's outbreak, and iGAS how important it is to have open, thoughtful, and scientific public health messaging, as well as the necessity of appropriate health and oversight mechanisms to prevent the sinking of medical facilities. Regretfully, early indications and symptoms of nausea are often unsettling and typical of numerous ailments, which makes these health messages more difficult to understand. Recent advancements in vaccination provide assurance that the burden of common childhood diseases may be lessened, but only if we can reverse the trend of declining vaccination rates and address disparities in community attitudes toward vaccinations.

5. STUDY LIMITATIONS

The heterogeneity of methodologies across included studies posed challenges in synthesizing findings. Future research should prioritize randomized controlled trials and longitudinal studies to strengthen evidence on NPIs' efficacy. This systematic review may have limitations in its scope. It focuses primarily on NPIs without a thorough quantitative analysis of their efficacy compared to pharmacological interventions. The rapid evolution of infectious diseases and the societal response to them can render findings to be outdated quickly. Since the study assesses NPIs in the context of the post-COVID-19 era, there may be an inherent temporal limitation in its applicability to future pandemics or outbreaks. The effectiveness and acceptance of NPIs can vary significantly based on cultural, social, and economic contexts. This review may not encompass all geographical regions equally, thus limiting the generalizability of its findings. While the review may draw upon existing studies, the absence of long-term data on the effectiveness of NPIs in controlling infectious diseases may hinder comprehensive conclusions. Most studies are based on short-term observations during the COVID-19 pandemic. The wide range of NPIs, from mask-wearing to lockdown measures, complicates the ability to draw unified conclusions about their overall effectiveness. The variability in implementation and adherence also contributes to this complexity.

6. FUTURE RESEARCH DIRECTIONS

Future research should focus on quantitative studies that analyze the effectiveness of NPIs in various contexts, providing clearer metrics for their impact on infectious disease control. There should be an emphasis on comparative studies that evaluate NPIs alongside pharmacological approaches. Understanding the synergistic effects of both strategies will provide a holistic view of infectious disease management. Conducting longitudinal studies that track the outcomes of NPIs over time will help to establish their long-term efficacy and potential adverse effects, like societal fatigue or economic impacts. Future research should consider cultural, social, and economic factors affecting NPI implementation and adherence. Understanding these variables can improve the design and implementation of interventions in diverse populations. Investigating the development of novel NPIs, including digital health technologies and behavioral nudges, could provide new avenues for managing infectious diseases in a post-pandemic world. Encouraging interdisciplinary research that integrates public health, sociology, psychology, and economics may yield more comprehensive strategies for managing infectious diseases through NPIs. By addressing these limitations and focusing on the suggested areas of future research, the understanding and implementation of NPIs in the fight against infectious diseases can be significantly enhanced.

CONCLUSION

NPIs will continue to play a critical role in managing infectious diseases in the post-COVID-19 era. Their effectiveness, when combined with pharmacological interventions, underscores the need for a holistic approach to public health. Policymakers and healthcare providers must remain vigilant, adapting strategies to emerging threats and integrating community-driven solutions.

AUTHORS’ CONTRIBUTION

The authors confirm their contribution to the paper as follows: study conception and design: EA; data collection, analysis and interpretation of results: EA, RR MK; draft manuscript: EA.

All authors reviewed the results and approved the final version of the manuscript.

LIST OF ABBREVIATIONS

COVID-19 = Coronavirus Disease 2019
NPI = Non-Pharmacological Intervention
PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses
WHO = World Health Organization

CONSENT FOR PUBLICATION

Not applicable.

STANDARDS OF REPORTING

PRISMA guidelines and methodology were followed.

AVAIALABILITY OF DATA AND MATERIALS

All the data and supportive information are provided within the article.

FUNDING

This research was done with the financial support of Dr. Elaheh Abiri.

CONFLICT OF INTEREST

The authors declared no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

Declared none.

SUPPLEMENTARY MATERIAL

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

Supplementary material is available on the publisher’s website along with the published article.

REFERENCES

1
Thakur P, Thakur V, Sapra M, Srivastava S, Patel SKS. Post COVID-19 era: Re-emergence of known and future (X) viral pathogens. Vacunas 2024; 25(3): 403-14.
2
Soni S, Mebratu YA. B‐cell lymphoma‐2 family proteins‐activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus‐2: Killing two birds with one stone? Rev Med Virol 2023; 33(2): e2411.
3
Raesi R, Khalesi N, Safavi M, Mirzaei A, Alimohammadzadeh K. Identifying the outcomes of healthy lifestyles in the Post-COVID-19 Era. Arch Adv Biosci 2023; 14(1): 1-14.
4
Shapo L, Puca E. What could drive the re-emergence of infectious diseases in a post-Covid19 era? Travel Med Infect Dis 2023; 52: 102546.
5
Amar S, Avni YS, O’Rourke N, Michael T. Prevalence of common infectious diseases after COVID-19 vaccination and easing of pandemic restrictions in Israel. JAMA Net Open 2022; 5(2): e2146175.
6
Gilligan P. Impact of COVID-19 on infectious diseases and public health 2022.
7
Abiri E, Raesi R, Kashani MHG. Investigating the role of non-pharmaceutical interventions (NPI) during pandemics: COVID-19 as an example. BMC Res Notes 2025; 18(1): 19.
8
Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023; 21(3): 195-210.
9
Kubra K, Kadir SAKM, Jobran AWM. Emergence and re-emergence of infectious diseases in South Asia: A call for action. Ann Med Surg 2022; 84: 104878.
10
Raesi R, Khalesi N, Safavi M, Mirzaei A, Alimohammadzadeh K. Identifying factors affecting a healthy lifestyle in the post-COVID-19 era. J Educ Health Promot 2024; 13(1): 130.
11
Rizvi RF, Craig KJT, Hekmat R, et al. Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis. SAGE Open Med 2021; 9: 20503121211022973.
12
Paul E, Brown GW, Bell D, Agris VJM, Ridde V. Royal Society report: What would a comprehensive evaluation suggest about non-pharmaceutical interventions during COVID-19? Crit Public Health 2024; 34(1): 1-10.
13
Mahase E. Covid-19: Lockdowns and masks helped reduce transmission, expert group finds 2023.
14
Oleribe O, Taylor-Robinson A, Nwanyanwu O, Morgan M, Taylor-Robinson S. Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa? Risk Manag Healthc Pol 2024; 17: 505-11.
15
Pabasara C, Paranagama R. Pandemic preparedness in South Asia: Outlining A plan for regional cooperation. 2022. Available from: https://blogs.lse.ac.uk/southasia/2022/01/10/pandemic-preparedness-in-south-asia-outlining-a-plan-for-regional-cooperation
16
Nijman RG. Along came COVID-19: The changing landscape of serious childhood infections. Global Pediatrics 2024; 7: 100120.
17
AbouKorin SAA, Han H, Mahran MGN. Pandemic resilience planning: NPI measures and Covid-19 impacts in UK, Germany, and Italy. Cities 2023; 143: 104621.
18
Han T, Wang Y, Zhang D, Li Y, Zhang L, Yan J. Changes in infant respiratory pathogens pre-during, and post-COVID-19 non-pharmacological interventions in Beijing. Res Square 2024; 1-9.
19
Lee D, Kang J, Kim K. Global collaboration research strategies for sustainability in the post COVID-19 era: Analyzing virology-related national-funded projects. Sustainability 2020; 12(16): 6561.
20
Zhao H, Jatana S, Bartoszko J, Loeb M. Nonpharmaceutical interventions to prevent viral respiratory infection in community settings: An umbrella review. ERJ Open Res 2022; 8(2): 00650-2021.
21
Cunningham N, Hopkins S. Lessons identified for a future pandemic. J Antimicrob Chemother 2023; 78(Suppl. 2): ii43-9.
22
Mohammadi Z, Cojocaru MG, Thommes EW. Human behaviour, NPI and mobility reduction effects on COVID-19 transmission in different countries of the world. BMC Public Health 2022; 22(1): 1594.
23
Shenai MB, Rahme R, Noorchashm H. Equivalency of protection from natural immunity in COVID-19 recovered versus fully vaccinated persons: A systematic review and pooled analysis. Cureus 2021; 13(10): e19102.
24
Organization WH. Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza: Annex: Report of systematic literature reviews 2019.
25
Burrell R, Saravanos G, Britton PN. Unintended impacts of COVID-19 on the epidemiology and burden of paediatric respiratory infections. Paediatr Respir Rev 2023; S1526-0542(23): 00044-1.
26
Perra N. Non-pharmaceutical interventions during the COVID-19 pandemic: A review. Phys Rep 2021; 913: 1-52.
27
ÓhAiseadha C, Quinn GA, Connolly R, et al. Unintended consequences of COVID-19 non-pharmaceutical interventions (NPIs) for population health and health inequalities. Int J Environ Res Public Health 2023; 20(7): 5223.
28
Hailemariam D, Kumie A, Wakuma S. Trends in non-pharmaceutical intervention (NPI) related community practice for the prevention of COVID-19 in Addis Ababa, Ethiopia PLoS One 2021; 16(11): e0259229.
29
Yang J, Zhang Q, Cao Z, et al. The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City. Chaos 2021; 31(2): 021101.
30
Greenhalgh T, MacIntyre CR, Baker MG, et al. Masks and respirators for prevention of respiratory infections: A state of the science review. Clin Microbiol Rev 2024; 37(2): e00124-23.
31
Chandan JS, Brown KR, Simms-Williams N, et al. Non-pharmacological therapies for post-viral syndromes, including Long COVID: A systematic review. Int J Environ Res Public Health 2023; 20(4): 3477.
32
Regmi K, Lwin CM. Factors associated with the implementation of non-pharmaceutical interventions for reducing coronavirus disease 2019 (COVID-19): A systematic review. Int J Environ Res Public Health 2021; 18(8): 4274.
33
Gedde MH, Husebo BS, Vahia IV, et al. Impact of COVID-19 restrictions on behavioural and psychological symptoms in home-dwelling people with dementia: A prospective cohort study (PAN.DEM). BMJ Open 2022; 12(1): e050628.
34
Zhu Y, Holden M. Housing and psychosocial well-being during the COVID-19 pandemic. Habitat Int 2023; 135: 102812.
35
Arnold L, Bimczok S, Schütt H, Lisak-Wahl S, Buchberger B, Stratil JM. How to protect long-term care facilities from pandemic-like events? - A systematic review on the effectiveness of non-pharmacological measures to prevent viral respiratory infections. BMC Infect Dis 2024; 24(1): 589.
36
Vardavas R, Lima DPN, Baker L. Modeling COVID-19 nonpharmaceutical interventions: Exploring periodic NPI strategies. MedRxiv 2021; 1-9.
37
Ullrich A, Schranz M, Rexroth U, et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020. Lancet Reg Health Eur 2021; 6: 100103.
38
Demirgüç-Kunt A, Lokshin M, Torre I. The sooner, the better: The economic impact of non‐pharmaceutical interventions during the early stage of the COVID‐19 pandemic. Econ Transit Inst Change 2021; 29(4): 551-73.
39
Chen M, Xu S, Husain L, Galea G. Digital health interventions for COVID-19 in China: A retrospective analysis. Intell Med 2021; 1(1): 29-36.
40
Ma W, Li X, Wang N, et al. Impact of non-pharmacological interventions on incidence of hand, foot and mouth disease during the COVID-19 pandemic: A large population-based observational study. BMC Infect Dis 2024; 24(1): 1353.
41
Wang Y, Yang J, Qiao F, et al. Compared hand hygiene compliance among healthcare providers before and after the COVID-19 pandemic: A rapid review and meta-analysis. Am J Infect Control 2022; 50(5): 563-71.
42
Organization WH. Health systems resilience toolkit: A WHO global public health good to support building and strengthening of sustainable health systems resilience in countries with various contexts 2022.
43
López L, Rodó X. Stochastic network to model the global spreading of respiratory diseases: From SARS-CoV-2 to pathogen X pandemic. Ecol Inform 2024; 83: 102827.